BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38898187)

  • 1. Navigating the penetrance and phenotypic spectrum of inherited cardiomyopathies.
    Serpa F; Finn CM; Tahir UA
    Heart Fail Rev; 2024 Jun; ():. PubMed ID: 38898187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias.
    Hayesmoore JB; Bhuiyan ZA; Coviello DA; du Sart D; Edwards M; Iascone M; Morris-Rosendahl DJ; Sheils K; van Slegtenhorst M; Thomson KL
    Eur J Hum Genet; 2023 Sep; 31(9):1003-1009. PubMed ID: 37443332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited cardiomyopathies: molecular genetics and clinical genetic testing in the postgenomic era.
    Teekakirikul P; Kelly MA; Rehm HL; Lakdawala NK; Funke BH
    J Mol Diagn; 2013 Mar; 15(2):158-70. PubMed ID: 23274168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic Advances.
    Fernández-Falgueras A; Sarquella-Brugada G; Brugada J; Brugada R; Campuzano O
    Biology (Basel); 2017 Jan; 6(1):. PubMed ID: 28146053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic cardiomyopathies.
    Wilcox JE; Hershberger RE
    Curr Opin Cardiol; 2018 May; 33(3):354-362. PubMed ID: 29561320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massive Parallel DNA Sequencing of Patients with Inherited Cardiomyopathies in Cyprus and Suggestion of Digenic or Oligogenic Inheritance.
    Koutsofti C; Ioannides M; Polydorou C; Papagregoriou G; Malatras A; Michael G; Hadjiioannou I; Pieri S; Loizidou EM; Eftychiou C; Papasavvas E; Christophides T; Alkelai A; Kapoor M; Shuldiner AR; Avraamides P; Deltas C
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized Interpretation and Clinical Translation of Genetic Variants Associated With Cardiomyopathies.
    Campuzano O; Fernandez-Falgueras A; Sarquella-Brugada G; Cesar S; Arbelo E; García-Álvarez A; Jordà P; Coll M; Fiol V; Iglesias A; Perez-Serra A; Mates J; Del Olmo B; Ferrer C; Alcalde M; Puigmulé M; Mademont-Soler I; Pico F; Lopez L; Tiron C; Brugada J; Brugada R
    Front Genet; 2019; 10():450. PubMed ID: 31156706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
    Kingdom R; Wright CF
    Front Genet; 2022; 13():920390. PubMed ID: 35983412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death.
    Coll M; Pérez-Serra A; Mates J; Del Olmo B; Puigmulé M; Fernandez-Falgueras A; Iglesias A; Picó F; Lopez L; Brugada R; Campuzano O
    Biology (Basel); 2017 Dec; 7(1):. PubMed ID: 29278359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Dalal D; James C; Devanagondi R; Tichnell C; Tucker A; Prakasa K; Spevak PJ; Bluemke DA; Abraham T; Russell SD; Calkins H; Judge DP
    J Am Coll Cardiol; 2006 Oct; 48(7):1416-24. PubMed ID: 17010805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Follow-Up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions.
    van den Heuvel LM; van Teijlingen MO; van der Roest W; van Langen IM; Smets EMA; van Tintelen JP; Christiaans I
    Circ Genom Precis Med; 2020 Oct; 13(5):524-530. PubMed ID: 33079600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable Penetrance and Expressivity of a Rare Pore Loss-of-Function Mutation (p.L889V) of Nav1.5 Channels in Three Spanish Families.
    Gallego-Delgado M; Cámara-Checa A; Rubio-Alarcón M; Heredero-Jung D; de la Fuente-Blanco L; Rapún J; Plata-Izquierdo B; Pérez-Martín S; Cebrián J; Moreno de Redrojo L; García-Berrocal B; Delpón E; Sánchez PL; Villacorta E; Caballero R
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance and Expressivity in Inherited Cancer Predisposing Syndromes.
    Taeubner J; Wieczorek D; Yasin L; Brozou T; Borkhardt A; Kuhlen M
    Trends Cancer; 2018 Nov; 4(11):718-728. PubMed ID: 30352675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and genetic causes of fetal cardiomyopathies.
    Kohaut E; Ader F; Rooryck C; Pelluard F; Bonnière M; André G; Sauvestre F; Roth P; Khraiche D; Bessières B; Attié-Bitach T; Richard P
    Clin Genet; 2023 Jul; 104(1):63-72. PubMed ID: 37209000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Novel Variant NP_00454563.2 (
    Robles-Mezcua A; Ruíz-Salas A; Medina-Palomo C; Robles-Mezcua M; Díaz-Expósito A; Ortega-Jiménez MV; Gimeno-Blanes JR; Jiménez-Navarro MF; García-Pinilla JM
    Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.